How To Create An Bioavailability Enhanced Formulation
Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…
Techniques for Choosing and Developing a Drug Candidate
Employing information regarding an active pharmaceutical ingredient’s physicochemical characteristics obtained from pre-formulation and formulation investigations enhances the probability of achieving success in…
Improving Therapeutic Compound Oral Bioavailability
Poor solubility remains an ongoing challenge in formulation development. Dr. Sridhar Gummudaveli, Director R &D shares insights on lipid-based drug-delivery systems to…
Customer Requirements for Oral Dose Development
Pharmaceutical developers aim for cost-effective oral medications that work well. This can be challenging, requiring an understanding of client, patient, and provider…
Translating Lab Discoveries: Preclinical to First-in-Human Development.
Overview Drug developers have to take into account several factors to position a pre-clinical drug candidate successfully for first-in-human clinical trials. This executive summary will outline…
Survey Reveals Orphan Drugs Companies are Hindered by Internal Limitations
Orphan drugs encounter challenges that extend from their initial discovery to eventual launch, primarily due to the restricted patient numbers and niche…
